Compare ANIP & RQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANIP | RQI |
|---|---|---|
| Founded | 2001 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.5B |
| IPO Year | 1999 | 2001 |
| Metric | ANIP | RQI |
|---|---|---|
| Price | $75.10 | $11.94 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $105.78 | N/A |
| AVG Volume (30 Days) | 314.1K | ★ 714.2K |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.20% |
| EPS Growth | ★ 419.23 | N/A |
| EPS | ★ 3.86 | N/A |
| Revenue | ★ $206,547,000.00 | N/A |
| Revenue This Year | $24.85 | N/A |
| Revenue Next Year | $10.76 | N/A |
| P/E Ratio | $18.56 | ★ N/A |
| Revenue Growth | ★ 2.47 | N/A |
| 52 Week Low | $69.58 | $10.81 |
| 52 Week High | $95.45 | $13.57 |
| Indicator | ANIP | RQI |
|---|---|---|
| Relative Strength Index (RSI) | 46.82 | 66.24 |
| Support Level | $69.93 | $11.69 |
| Resistance Level | $74.29 | $13.45 |
| Average True Range (ATR) | 1.83 | 0.20 |
| MACD | 0.00 | 0.10 |
| Stochastic Oscillator | 38.27 | 98.04 |
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.
COHEN & STEERS QUALITY INCOME REALTY FUND INC is a diversified, closed-end management investment company. The primary investment objective of the fund is high current income through investment in real estate securities. The Fund's secondary objective is capital appreciation. The Fund invests at least its total assets in income-producing common stocks and other securities issued by real estate companies, such as real estate investment trusts under normal market conditions.